ghk cu anti inflammatory antioxidant properties Frontiers Peptide Therapy for Inflammation: A

Xie Y, Zheng J, Li S, Li H, Zhou Y, Zheng W, et al

Mol Psychiatry 27:803818

Weeks on a shelf is not

Research involving GHK-Cu has examined interactions with signaling networks associated with extracellular matrix regulation, structural protein organization, metal-ion transport processes, and peptide-mediated cellular communication

Phase 3 TRIUMPH topline figures (often cited around the high-20% range at 6880 weeks) are company-reported and, at the time of writing, are not the peer-reviewed Phase 2 dataset cited above

That being said, the high doses of the nootropic measured at 0.5 mg/kg/day for intraperitoneal delivery and 2.0 mg/kg/day for oral delivery, and resulted in a performance that was indistinguishable from the control group and significantly better than the animals treated with scopolamine alone [2]